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ABSTRACT
Objectives To explore young people’s experiences of 
eczema self- management and interacting with health 
professionals.
Design Secondary qualitative data analysis of data sets 
from two semistructured interview studies. Data were 
analysed using inductive thematic analysis.
Setting Participants were recruited from the UK primary 
care, dermatology departments and a community- based 
sample (eg, patient representative groups, social media).
Participants Data included 28 interviews with young 
people with eczema aged 13–25 years (mean age=19.5 
years; 20 female).
Results Although topical treatments were generally 
perceived as effective, young people expressed doubts 
about their long- term effectiveness, and concerns around 
the safety and an over- reliance on topical corticosteroids. 
Participants welcomed the opportunity to take an active 
role in their eczema management, but new roles and 
responsibilities also came with initial apprehension and 
challenges, including communicating their treatment 
concerns and preferences with health professionals, 
feeling unprepared for transition to an adult clinic and 
obtaining treatments. Decisions regarding whether to 
engage in behaviours that would exacerbate their eczema 
(eg, irritants/triggers, scratching) were influenced by young 
people’s beliefs regarding negative consequences of these 
behaviours, and perceived control over the behaviour and 
its negative consequences.
Conclusions Behavioural change interventions must 
address the treatment concerns of young people and equip 
them with the knowledge, skills and confidence to take an 
active role in their own eczema management.
INTRODUCTION
Eczema is a common skin condition that can 
have a significant effect on an individuals’ 
quality of life, mainly due to persistent itching 
and pain, sleep disturbance and emotional 
distress.1 2 Although eczema typically starts 
in infancy and epidemiology studies show 
that it typically improves or resolves by late 
childhood,3 4 for many, symptoms can persist 
into adolescence and adulthood.5 For most, 
eczema management focuses on the regular 
use of emollients to retain the skin’s barrier 
function; treating flare- ups using topical 
corticosteroids (TCS); identification and 
avoidance of irritants/triggers; and avoiding 
scratching, which can further exacerbate 
eczema symptoms.6 For those with moderate 
and severe eczema, management may also 
involve use of topical calcineurin inhibitors, 
bandages or medicated dressings, systemic 
therapy (immunosuppressants) and photo-
therapy (light therapy).6
Self- management can be particularly chal-
lenging during adolescence and early adult-
hood. Young people must take on a more 
active role in their eczema management, a 
role that was previously the primary respon-
sibility of their families. They experience 
new demands, including understanding and 
adhering to complex treatment regimens; 
financing, acquiring and testing effective 
medical treatments; interacting with health 
professionals; and negotiating healthcare 
systems. Such demands can serve to disrupt 
their health and well- being, and may lead 
to non- adherence and ineffective resource 
use.7–9
The unique self- management challenges 
and preferences of this group are largely not 
Strengths and limitations of this study
 ► Our findings provided a more in- depth understand-
ing of young people’s unique experiences of eczema 
self- management and interactions with health pro-
fessionals, which are largely not understood.
 ► Our in- depth data set included diverse views from 
young people across a wide age range and from dif-
ferent ethnic groups.
 ► Although researchers from the primary research 
were involved in the data analysis, secondary analy-
sis can overlook the socio–cultural–political context 
under which the research was originally conducted.
 ► For one interview study, sections of the data set 
were to be published online, which meant that some 
participants may have been particularly motivated 
and may give socially desirable answers.
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understood.10 A recent systematic review found that most 
qualitative studies sampled young people with eczema 
alongside adults, children or people with other skin 
conditions, making it difficult to tease out the unique 
experiences of this group.10 The current study is the 
third from our research team to explore young people’s 
experiences of eczema and its management. Each study 
involved a secondary data analysis of a large qualitative 
data set derived from two primary studies exploring 
young people’s experiences of eczema, but focused 
on a different aspect of these accounts. The first study 
explored perceptions about the nature of eczema (eg, as 
an episodic long- term condition) and how these percep-
tions related to their self- care and adaptation to eczema.11 
The second study explored young people’s experiences 
of eczema- related symptoms (both visible and invisible 
to others) to determine their psychosocial needs.12 The 
current study aims to explore young people’s experiences 
of eczema self- management and interacting with health 
professionals. This study will go beyond previous quali-
tative studies with young people9 by exploring perceived 
challenges around other self- management behaviours 
(ie, avoiding irritants and triggers, reducing scratching), 
as well as topical treatments and, crucially, their experi-
ences of taking an active role in eczema management.
METHODS
Design and data collection
The study design was a secondary analysis of qualitative 
interview data, drawing on two data sources. Although 
both studies had different aims, both used interview ques-
tions relevant to this study aim, exploring experiences of 
eczema treatments and management, and interactions 
with health professionals.
SKINS project
This project aimed to explore young people’s experiences 
of living with common skin conditions (eczema, acne, 
psoriasis, alopecia) and share these on  healthtalk. org. 
Participants were recruited from health settings, patient 
representative groups, educational institutions and social 
media. Maximum variation sampling was used to recruit 
a range of demographics.13 Twenty- four of the 97 inter-
views were with young people (aged 17–25 years) with 
eczema and all but one consented for their data to be 
used for this secondary analysis. Semistructured interviews 
were carried out by AM (qualitative health researcher) 
between October 2014 and December 2015. They took 
place at the participants’ homes or alternative meeting 
places, and lasted up to 2 hours. Interview topics included 
views about eczema treatment and management; experi-
ences of healthcare; and advice for others with eczema 
and health professionals (online supplemental file 1). 
Interviews were either audio or video recorded and tran-
scribed verbatim, and checked by participants for accu-
racy. All three of our secondary data analysis studies drew 
on this data source.
Eczema care online project
As part of a wider project to develop an online interven-
tion for young people with eczema, a survey and semi-
structured interviews were carried out with this group. 
Interviews recruited younger adolescents (13–16 years) 
who were not captured in the SKINS sample. Sixteen 
general practitioner (GP) practices and three hospitals 
across Wessex provided an invitation letter, participant 
information sheet and survey to 1123 young people with 
eczema (aged 13–25 years). Fifty- five young people agreed 
to take part in the interviews, 12 were 13–16 years old. 
Participants were purposively sampled to ensure a range 
of ages and a balance of genders. Five young people took 
part in the interviews. Those who did not take part in the 
interview either could not be contacted by telephone 
or were not selected for purposive sampling. This data 
source was also used in one of our other secondary data 
analysis studies.12
DG (expertise in paediatric psychology and qualita-
tive research) interviewed participants at their homes 
during March–May 2018 lasting 22–50 min. Participants’ 
parents were present for three of the interviews. Interview 
topics included views and experiences of eczema, treat-
ments, self- management, and information and support 
for eczema (online supplemental file 2). Interviews were 
audio recorded and transcribed verbatim.
Of the 28 participants overall, 20 were female and 8 
male. Participants had a mean age of 19.5 years and had 
eczema for a period of 8 months to all their life (table 1).
Patient and public involvement
Our patient collaborator (AR) has eczema and chil-
dren with eczema, and helps run a support group for 
carers of children with eczema. She was a co- applicant 
on the research grant application, helping to iden-
tify the research topic and develop research questions. 
She attended regular project meetings, discussed and 
provided feedback on our interpretations of the findings, 
and provided feedback on the eczema care online (ECO) 
study materials and this manuscript. She continues to 
help us to disseminate our research findings among her 
wide- reaching patient networks and via social media. Two 
young people reviewed the ECO participant information 
sheet to check comprehension. For the SKINS project, 
eight patient and public involvement (PPI) representa-
tives (including young people with eczema, parents and 
skin charity members) attended advisory group meetings 
and reviewed the interview schedule and summaries of 
the findings.
Data analysis
Both data sets were analysed together by following the six 
stages of Braun and Clarke’s inductive thematic analysis14 
and data handling was facilitated using NVivo V.12 Pro. 
DG carried out initial coding on the entire SKINS data 
set, familiarising herself with the data and generating 
initial codes that represented the various topics present 
across the data (eg, barriers to emollients, experiences 
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with health professionals). A coding manual was created, 
including descriptions of the codes and example quotes, 
and DG discussed this with KG, IM (both health psychol-
ogists experienced in qualitative research) and MS 
(GP experienced in qualitative research). These three 
researchers used the manual to code two transcripts, 
and changes to the coding manual were made following 
discussions. The revised coding manual was discussed 
with a PPI representative (AR) and the interviewer for 
the SKINS project (AM). It was agreed that the findings 
would be reported across three separate studies (the 
other two are reported elsewhere11 12).
For this study, KG reviewed the initial codes deemed 
relevant to the study aim, redefined them in line with 
this aim, searched for, reviewed and defined themes, 
and created a coding manual for this study. KG then 
familiarised herself with the ECO data, and coded the 
data, identifying any data that deviated from the SKINS 
data (eg, any new codes or experiences) in the coding 
manual. Disconfirming cases were identified throughout 
the entire data set. Writing up the thematic analysis in 
this manuscript helped finalise the analysis, enabling the 
final themes to be reviewed and agreed by all coauthors. 
Pseudonyms were given to all participants.
An important quality criterion in qualitative research 
is the adequacy of the sample size. This can be assessed 
by consideration of a study’s ‘information power’15 and 
whether data saturation was reached.16 Drawing on the 
guidelines on information power in qualitative interview 
studies,15 our sample size for the secondary data anal-
ysis (n=28) was deemed adequate given the specificity 
of the study aim (self- management) and target group 
(young people), the large amount of data (in particular 
from the SKINS interviews, which lasted up to 2 hours) 
and the likely high quality of dialogue from using expe-
rienced qualitative postdoctoral researchers. It was also 
comparable with other qualitative interview studies 
exploring experiences among people with eczema.10 
When analysing the SKINS data, we felt that data satura-
tion was reached as the later interviews did not identify 
any additional codes or diversely different experiences 
or views.16 Although the analysis of the ECO project data 
did not identify any additional codes (ie, code saturation 
was reached16), the analysts felt that additional interviews 
with this age group were needed to be confident that the 
issues facing this group are fully understood (ie, meaning 
saturation was not reached for this group16).
RESULTS
The five themes and the key findings under each theme 
are summarised in figure 1.
Beliefs about the effectiveness of topical treatments
Generally, young people believed that their topical 
treatments (emollients and TCS, topical calcineurin 
inhibitors) were effective. However, many described expe-
riences whereby certain treatments had stopped working 
with time or caused new side effects (eg, burning). This 
led them to change emollient or TCS, apply increasingly 
more treatment to get the same effect or try a stronger 
TCS. Some participants attributed the reduced effective-
ness of the treatments over time to their skin adapting to 
treatments (mainly emollients).
I can use one moisturiser for six months, a year, and 
then my skin will get too used to it and I’ll have to 
Table 1 Demographics of participants from the two data 
sources
  Frequency %
SKINS project
Gender
  Male 6 26
  Female 17 74
Age (years)
  16–18 4 17
  19–21 10 43
  22–24 9 39
Ethnicity (self- identified)
  White British 13 57
  British Indian 3 13
  Bangladeshi 2 9
  Pakistani 2 9
  Indian 1 4
  Mixed—Black Caribbean and White 1 4
  Mixed—White and Algerian 1 4
  White Hungarian 1 4
Duration of condition
  All life (diagnosis before first birthday) 16 70
  11–21 years (diagnosis in toddler years) 4 17
  5–7 years (diagnosis in adolescence 
years)
2 9
  Up to 1 year (diagnosis in young adult 
years)
1 4
Eczema care online project
Gender
  Male 2 40
  Female 3 60
Age (years)
  13–14 2 40
  15–16 3 60
Duration of condition
  All life (diagnosis before first birthday) 4 80
  3 years (diagnosis in adolescence years) 1 20
Eczema severity (self- identified)
  Moderate 3 60
  Moderate/severe 1 20
  Mild 1 20
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keep putting more on. Then I’ll end up having to 
switch to a different kind of moisturiser just so I can 
get it under control again. (Cassie, female, 15 years 
old, eczema since birth, ECO project)
Switching around [emollients], generally, does make 
a difference. (Mali, male, 23 years old, eczema for 20 
years, SKINS project)
A minority reported how they had tried certain topical 
treatments (mainly TCS) that made their eczema worse, 
and a few did not find topical treatments made a differ-
ence to their eczema. A few participants stopped using 
emollients when their eczema was better or used them 
only when their eczema was problematic: “I’m sort of 
taking the ‘if it isn’t broke don’t fix it’ route with my skin.” 
(Eevi, female, 22 years old, eczema since birth, SKINS 
project).
Concerns about topical treatments
Many young people expressed a general caution or hesi-
tancy around using TCS, listing side effects (eg, burning) 
or long- term effects they had experienced or had heard 
about (eg, skin thinning, skin ageing, impairing immune 
system). For some, this cautiousness was about acknowl-
edging the importance of using TCS correctly and 
avoiding excessive and unnecessary use, whereas others 
actively avoided using TCS or only used them when their 
eczema was very bad. Two participants expressed concerns 
that TCS might cause eczema to ‘spread’ or move around 
the body:
I feel that steroids sort of suppress it [eczema] and 
it crops up somewhere else…I want to get rid of the 
whole thing, not just have this internal thing inside 
me that will just crop up when and where because I’m 
not using something to suppress it. (Iris, female, 20 
years old, eczema for 16 years, SKINS project)
Some participants were worried about becoming 
‘reliant’ on TCS, having to use more, or increasingly 
stronger, TCS or having to use them indefinitely. Many 
of their TCS concerns had originated from stories 
about potential side effects they had read or heard from 
others.
[I] met a girl who said that they [TCS] had the 
capacity to change your sexuality…so since then 
I’ve been really nervous [to use them]. (Hannah, 
female, 20 years old, eczema for 16 years, SKINS 
project)
[I] read about a lady…she used steroids for such a 
long time that it’s definitely sort of had an adverse 
sort of reaction to her body…her hair’s thinned and 
her…nails are brittle. (Dua, female, 21 years old, ec-
zema for 20–21 years, SKINS project)
Such concerns about side effects led some participants 
to switch to using more ‘natural’ products to help eczema, 
sometimes against or at least without consulting medical 
advice. Natural (or homemade) products were viewed as 
‘healthy’, described as containing no or fewer chemicals, 
and less likely to cause side effects.
I wanted to stay away from that [potent TCS] be-
cause…I like naturally occurring products…my der-
matologist…wasn’t too happy for me to go down the 
route without steroids I think because…it does have 
a really high success rate. I won’t deny that. (Iris, 
female, 20 years old, eczema for 16 years, SKINS 
project)
Figure 1 Visual representation of themes and key findings.
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Two participants described how they had experienced 
side effects (red, heated and stinging skin) from using a 
topical calcineurin inhibitor.
Compared with TCS, young people expressed fewer 
concerns regarding the safety of emollients. A few partici-
pants explained how emollients can ‘block’ their skin and 
one expressed concerns about the flammability of emol-
lients containing paraffin.
Participants found that topical treatments, specifically 
emollients that are applied regularly in large amounts, can 
be unpleasant in texture and/or smell, can make it diffi-
cult to use certain object (such as a pen), can rub off onto 
other items, such as clothes or bedding, can make them 
feel hot, sweaty or ‘dirty’, and can sting when applied. 
Some avoided applying creams in public as they did not 
want others to ‘find out’ they had eczema. They worried 
that others could smell their treatments, or that people 
would not want to touch them (eg, partners holding their 
hand) if they had creams on. However, some explained 
how such worries reduced as they got older and started to 
care less about the others’ opinions.
My colleagues often see me moisturising at my desk. 
They don’t mention it [laughs] And if people think 
it’s a bit weird, like I feel bad, but also like it’s so un-
comfortable when you can’t moisturise. (Willow, fe-
male, 23 years old, eczema since birth, SKINS project)
Burden of eczema self-management
Participants explained how burdensome eczema self- 
management could be. Applying topical treatments, iden-
tifying and avoiding irritants/triggers (especially as there 
are potentially so many), resisting the urge to scratch, 
and the ‘trial and error’ process of finding effective and 
acceptable (eg, does not sting) treatments were described 
to be time- consuming, effortful, frustrating, and some-
times expensive.
It was quite a repetitive experience of just back and 
forth and back and forth. You’d explain [to the doc-
tor], ‘oh okay well it’s not working’, like ‘okay let’s, 
let’s higher the dosage. Or let’s try and find some ste-
roids in’, it just would not work. (Raashid, male, 24 
years, eczema since birth, SKINS project)
Some days you just can’t be bothered. If you’re out 
with friends, you know it’s time to put on your cream; 
you would ignore it and during that night, I’d some-
times suffer the consequences…and I was scratching 
and itching all the time. (Qamar, male, 18 years old, 
eczema for 11 years, SKINS project)
As can be seen in the above quote, treatment burdens 
led some young people to skip treatments, especially 
when they had little time or energy.
Overcoming barriers to eczema self-management
Young people listed several practical barriers to eczema 
self- management and shared strategies they found helpful 
for overcoming these. Participants found it challenging 
to use their topical treatments (mainly emollients) when 
outside of the home. Specifically, it was difficult to use 
creams during class or take them when travelling abroad 
on a plane (due to luggage restrictions); or apply them if 
they worked in a public- facing job (eg, retail or waiter). 
Other barriers to accessing treatments included running 
out of treatments, being unable to get a doctor’s appoint-
ment to request more treatment (especially if they are 
living away from home and need to register with a GP) or 
treatment brands becoming discontinued. One younger 
participant from the ECO project reported that he found 
it hard to know how much emollient to apply. Participants 
found it helpful to keep sample- sized emollients or emol-
lients decanted into smaller containers with them (eg, in 
their bag) or around the house, to apply emollient before 
and after they leave the house, to stock up on treatments 
to avoid running out and to be able to buy treatments 
without a prescription.
Young people explained how it could be difficult to 
remember to apply topical treatments and emphasised the 
importance of having a routine for applying treatments 
(especially their emollients), applying their creams at the 
same time each day or making time to apply the creams: 
“The biggest thing for fighting eczema is routine…do 
something that you think is working and do it regularly…
don’t be disorganised with it.” (Zaahira, female, 21 years 
old, eczema since birth, SKINS project).
Although young people acknowledged the importance 
of avoiding irritants and triggers, they explained that 
it could be difficult to control your environment, for 
example, staying at a friend’s house, or in shared accom-
modation or an office environment. There were also 
external factors that they perceived to be unavoidable or 
outside of their control, such as the weather or stress.
Many participants commented on the cost of topical 
treatments, and cosmetics or washing products (eg, 
shower gels, laundry detergents) that do not cause 
flare- ups. When they were younger, participants’ treat-
ments were free on the National Health Service, but many 
had to pay for their treatments from the age of 18 years. 
This cost prevented some from getting more treatment or 
led them to buy non- prescription treatments instead (eg, 
over- the- counter medications). Participants particularly 
resented the cost when buying treatments or products 
that were ineffective or made their eczema worse.
I don’t want to go to the doctors and I don’t want to 
get more prescriptions because it just costs so much…
once I had to fork out sort of about £36 worth of med-
ications just for one particularly bad flare- up…and 
then if it doesn’t work you’re like, ‘What, I spent £40 
on nothing’. (Dua, female, 21 years old, eczema for 
20–21 years, SKINS project)
Some participants explained how they were still eligible 
for free prescriptions or obtained prescription prepay-
ment certificates, which helped with their prescription 
costs.
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Taking control of eczema self-management
Young people shared their experiences of taking control 
of their own eczema management. They explained how, 
when they were a child, their parents did the majority of 
their eczema management. As they became a teenager, 
they started taking greater responsibility for, and playing 
a more active role in, their eczema care. Generally, this 
transition was welcomed by participants and seen as a 
positive step towards becoming independent, a goal that 
was important to them.
As a child, I wasn’t managing [eczema] at all, I’d let 
my parents do it [applying cream] whenever they felt 
like it needed being doing. But I wouldn’t be applying 
my cream…And as [a] teen, I realised that it was my 
problem and that I should be doing it and obvious-
ly as a teen you want your independence. You don’t 
want your parents like stripping you off and covering 
you in bandages and cream. (Jamila, female, 20 years 
old, eczema since birth, SKINS project)
My mum has always wanted to come with me to my 
appointments when I was older. But I’ve always said, 
‘I want to do it on my own because I want to speak to 
my doctor.’ Cos [laughs] she had a habit when I was 
younger of coming with me to the doctor and…de-
ciding what was being done for me. (Iris, female, 20 
years old, eczema for 16 years, SKINS project)
Like Jamila in the quote above, young people’s drive for 
independence was prompted by a realisation that eczema 
management was their ‘problem’ (rather than their 
parents’ or health professionals’) and they would have to 
live with the consequences of poorly managed eczema. 
For some, independence was important for maintaining 
privacy and avoiding their parents seeing them as vulner-
able or distressed.
In contrast, some young people highlighted initial 
apprehension or challenges with these new roles and 
responsibilities, including moving to an adult clinic, 
having to do more things for themselves and taking an 
active role in their medical consultations.
I’m not really looking forward to that because…they 
don’t tell you what to do apparently in the adult clin-
ic…you have to be by yourself in the adult clinic so 
you have to…pay more attention and they’re not go-
ing to help me out as much as the children’s nurse 
would. (Adi, male, 17 years old, eczema for 6.5–7 
years, SKINS project)
Although young people were keen to take an active 
role, some found it intimidating to talk to health profes-
sionals or question their suggested treatments.
When I go to the doctors I feel like they’re the person 
in charge so I can’t really sort of be like, you know, 
‘I know that this suits me best’…I think you do get 
intimidated…they sort of just give you like, you know 
that doctor tone, they’re just a little bit better than 
you…and you’re like, ‘OK I guess you guys are right 
but [pause]’. (Dua, female, 21 years old, eczema for 
20–21 years, SKINS project)
Many participants experienced times when their 
doctors or pharmacists were reluctant to prescribe their 
preferred treatments or refer them to a dermatologist. 
Conversely, some participants shared positive experiences 
of obtaining their preferred treatments from their health 
professionals and praised them for listening to them 
and their willingness to try different treatments. Willow 
(female, 23 years old, eczema since birth, SKINS project) 
explained how she asked her GP if she could be given a 
topical calcineurin inhibitor after a friend with eczema 
had recommended it. Although her GP prescribed it for 
her, she felt frustrated that she had to find out about this 
herself and the GP had not recommended it to her earlier. 
Young people stressed the importance of doing your own 
research around treatments (eg, looking online), being 
‘confident’ or ‘insistent’ when communicating needs and 
preferences to health professionals, and writing a list of 
things to discuss beforehand.
Despite their changing role, the young people’s families 
were still an important source of support for them: driving 
them to appointments, providing advice on eczema 
management, helping them apply topical treatments in 
difficult- to- reach areas, helping them understand what 
the doctor said and speaking on their behalf at medical 
appointments when they felt unable to. This support was 
particularly important for early to mid- adolescents whose 
parents were still involved in their eczema management.
[When I apply treatments depends on] how I’m 
feeling at the time. So if Mum’s at the point of, ‘Oh 
[participant name], go put your creams on’, I’m like, 
‘Okay, I’ll go put my creams on’ and I’ll do it. Then 
I’ll come downstairs and she’s double checking, ‘Oh 
have you done your creams?’ At times she’d say it and 
I’ll say, ‘Yes, I’ll go do it and then I’ll completely for-
get,’ and that [is] pretty much the days where I would 
not do them. (Ben, male, 14 years old, eczema for 6 
months, ECO project)
When deciding whether to engage in specific self- 
management behaviours, participants considered 
whether doing so was worth the potential impact it 
would inevitably have on their eczema. For example, 
decisions around avoiding irritants/triggers were influ-
enced by how difficult it was to avoid (eg, if it was their 
favourite food, if everyone around them is drinking 
alcohol or eating a certain food), their belief about how 
much it would make their eczema worse and whether 
any action could be taken to minimise these conse-
quences (eg, by applying emollients or taking antihista-
mines afterwards).
If I cut out lactose I don’t think that it would make 
that much of a difference, so I might as well just eat 
the cheese and be happy. (Eevi, female, 22 years old, 
eczema since birth, SKINS project)
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I’d probably just carry on doing them [sports] and 
just sort of live with the consequences so, as long as 
you…go and have a shower afterwards and…cool 
down…if I’m having fun doing something then I’m 
not going to stop just cos of eczema. (Lanie, female, 
24 years old, eczema for 20+ years, SKINS project)
Participants were aware of the negative consequences 
of scratching, however, many found it difficult to avoid 
scratching completely. This was because a lot of their 
scratching was done subconsciously, it was a habit, many 
of the self- management strategies (eg, tapping) were inef-
fective or the relief of scratching was rewarding.
I’m terrible for scratching. I cannot stop myself. It’s 
like an addiction cos it relieves such a horrible sen-
sation all round my body. (Iris, female, 20 years old, 
eczema for 16 years, SKINS project).
I normally try to stop, like stop myself from doing it, 
but it gets to the point where it’s just all over, all over 
my neck and I just have to scratch it. (Amelia, female, 
15 years old, eczema for 12 years, ECO project)
DISCUSSION
Our findings provided a more in- depth understanding 
of young people’s unique experiences of eczema self- 
management. Specifically, the challenges they face 
when learning how to take an active role in their self- 
management: an issue that has not been explored in 
previous research. Although the new roles and respon-
sibilities around eczema management were generally 
welcomed by young people, they also brought initial 
apprehension and challenges. These findings mirrored 
previous research highlighting that young people often 
feel unprepared when transitioning from paediatric to 
adult care.17 18
Participants in this study found it hard to communicate 
their needs and treatment concerns to health profes-
sionals, which meant that, at times, they left consultations 
feeling like they were not listened to or were dissatisfied 
with the recommended course of action. Our previous 
qualitative study with this group found that young people 
with eczema have a strong need to feel understood and 
‘taken seriously’ by their health professionals.12 The 
more confident and competent young people feel in 
communicating their needs to health professionals, the 
more understood and validated they are likely to feel. 
There is a need for health professionals to acknowledge 
and encourage young people’s desire to become active 
contributors to their own healthcare, treating them as an 
equal partner in their care, while recognising that this 
new role may be initially daunting for some.19
Our study explored how young people decide whether 
to engage in behaviours that would exacerbate their 
eczema (eg, irritants/triggers, scratching). Previous 
research has focused predominantly on the perceived 
benefits and costs of topical treatments.10 Young people’s 
decisions were influenced by their beliefs regarding 
the negative consequences of the behaviours, and their 
perceived control over the behaviour and its negative 
consequences. People with eczema have a desire to live 
a ‘normal’ life and not allow their eczema management 
to impact on their everyday lives.10 12 Behavioural change 
interventions can help promote self- management and, 
as argued by the Self- determination Theory, such inter-
ventions are more effective if they enhance an individ-
ual’s need for autonomy and minimise conscious effort 
and lifestyle disruption.20–22 It is important to support 
young people to decide which of these behaviours can 
be avoided and how to minimise the consequences of 
unavoidable irritants/triggers, focusing on what is posi-
tive and possible.19
The Burden of Treatment Theory23 provides a useful 
framework for interpreting our study findings and 
making implications for practice. It argues that health 
interventions can minimise treatment burdens by 
building an individual’s cognitive and material capacity 
to perform self- management tasks. In the context of 
our findings, this may involve building a young person’s 
knowledge and skills required for making informed treat-
ment decisions and weighing up the benefits and costs 
of self- management behaviours. For example, the finan-
cial cost of treatments is a common barrier among young 
people.10 To build their material capacity, health profes-
sionals should acknowledge young people’s concerns 
around the costs and educate them regarding any finan-
cial support that is available to them. The Burden of 
Treatment Theory argues that interventions should build 
and strengthen ‘relational networks’ (ie, social networks, 
health professionals) around patients, and equip them 
to effectively navigate healthcare systems. Eczema inter-
ventions should build young people’s confidence and 
communication skills and support them to make deci-
sions, so they can direct their own care and feel prepared 
when transitioning to adult clinics.19
There are several limitations to this study. Secondary 
qualitative analysis has been criticised for not considering 
the socio–cultural–political context under which the 
primary research was conducted.24 This issue is particu-
larly salient for this study as the two sets of primary data 
were collected at two different time points. However, to 
minimise such decontextualisation, avoid any misinter-
preted data and ensure the final interpretations were 
representative of both data sets, the interviewers of both 
data sets were coauthors (DG, AM).
Although both primary studies explored the topics 
relevant to the aims of the current study, these studies 
were conducted for different purposes (ie, to inform two 
different health interventions), which may have intro-
duced differences in the data. For example, sections of 
the transcriptions and, with participant consent, audio 
and video clips from the SKINS interviews were to be 
published online. Therefore, compared with the ECO 
study participants, SKINS participants may have been 
more motivated and more likely to give socially desirable 
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answers. Despite this, our analysis highlighted that there 
was a great deal of convergence between the two data sets 
and our use of disconfirming case analysis ensured that 
any differences were identified and acknowledged. Our 
findings are also congruent with other data sets.9 10 17 18
As this was a secondary data analysis, it was not possible 
to carry out additional interviews in order to have full 
confidence that data saturation was reached. Moreover, 
the sample included only eight male. Additional inter-
views with adolescents aged 13–16 years and male with 
eczema may have enabled us to explore any differences 
between the age groups and between genders in more 
depth.
In conclusion, our findings highlight key self- 
management challenges faced by young people with 
eczema. Behavioural change interventions must address 
the treatment concerns of this group and equip them 
with the knowledge, skills and confidence to take an 
active role in their eczema management.
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